Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
03 09 2019
Historique:
received: 26 06 2017
revised: 13 11 2017
accepted: 06 12 2017
pubmed: 27 1 2018
medline: 23 7 2020
entrez: 27 1 2018
Statut: ppublish

Résumé

Streptococcus pneumoniae is increasingly recognised as an important cause of bacterial meningitis in the African meningitis belt. The World Health Organization sets guidelines for response to outbreaks of meningococcal meningitis, but there are no current guidelines for outbreaks where S. pneumoniae is implicated. We aimed to evaluate the impact of using a similar response to target outbreaks of vaccine-preventable pneumococcal meningitis in the meningitis belt. Here, we adapt a previous model of reactive vaccination for meningococcal outbreaks to estimate the potential impact of reactive vaccination in a recent pneumococcal meningitis outbreak in the Brong-Ahafo region of central Ghana using weekly line list data on all suspected cases over a period of five months. We determine the sensitivity and specificity of various epidemic thresholds and model the cases and deaths averted by reactive vaccination. An epidemic threshold of 10 suspected cases per 100,000 population per week performed the best, predicting large outbreaks with 100% sensitivity and more than 85% specificity. In this outbreak, reactive vaccination would have prevented a lower number of cases per individual vaccinated (approximately 15,300 doses per case averted) than previously estimated for meningococcal outbreaks. Since the burden of death and disability from pneumococcal meningitis is higher than that from meningococcal meningitis, there may still be merit in considering reactive vaccination for outbreaks of pneumococcal meningitis. More outbreak data are needed to refine our model estimates. Whatever policy is followed, we emphasize the importance of timely laboratory confirmation of suspected cases to enable appropriate decisions about outbreak response.

Identifiants

pubmed: 29371015
pii: S0264-410X(17)31832-7
doi: 10.1016/j.vaccine.2017.12.069
pii:
doi:

Substances chimiques

Meningococcal Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5657-5663

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Laura V Cooper (LV)

Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. Electronic address: lvc32@cam.ac.uk.

James M Stuart (JM)

Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Charles Okot (C)

WHO Country Office Ghana, Accra, Ghana.

Franklin Asiedu-Bekoe (F)

Ghana Health Service, Accra, Ghana.

Osei Kuffour Afreh (OK)

Brong Ahafo Regional Health Directorate, Sunyani, Brong Ahafo, Ghana.

Katya Fernandez (K)

World Health Organization Health Emergencies Programme, Geneva, Switzerland.

Olivier Ronveaux (O)

World Health Organization Health Emergencies Programme, Geneva, Switzerland.

Caroline L Trotter (CL)

Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH